HBI Exclusive News

 

Synlab and Cerba looking for exits, while Unilabs in ‘no rush’

The COVID-19 pandemic has uniquely warped revenue for the big lab groups. Difficulty forecasting means Apax is in “no rush” to explore an exit while Cerba Healthcare may join Synlab in an IPO process, HBI can reveal. Synlab is reportedly on an IPO roadshow this week and Biogroup’s recent record-breaking raise on the bond market shows there’s an investor appetite. 

NMC CEO: Any sale will be a competitive, traditional process

Will the creditors of NMC Healthcare, the GCC's largest for-profit healthcare operator which has been in administration since April 2020, choose a sale of its core UAE business in the next 3-6 months or a longer-term, creditor-led restructuring? We talk exclusively to NMC CEO Michael Davis and UAE sources. A 'fire sale' of parts of its core UAE business now seems entirely off the table.

Revealed: Babylon’s real revenue in 2020

Recently filed accounts for UK telehealth unicorn Babylon show the group made £6m sales with almost £100m losses in 2019. However, a well-placed source gives HBI a more accurate picture of the holding company's accounts, filed privately in Jersey.

Orpea to build universities across world after academy acquisition

Pan-European nursing home group Orpea has acquired a training academy in Austria, HBI can reveal. It signals a new wave for the group, which tells HBI that it wants to be known in five to ten years as a school, alongside its care and property arms. It will use the licence to build a university campus, doubling the number of people trained locally, and then duplicate this model across all its markets.

Appointment of new Artemis CEO lends weight to sale rumours

The CEO of Artemis Group, Germany's second largest ophthalmology chain by revenue, is stepping down from his position as CEO next week to be replaced by the former MD of German rehabilitation specialist Median Kliniken, who is also an ex McKinsey & Company consultant and investment house managing director. A source tells us this is being done in anticipation of a sale.

Aetna Global Benefits for sale

The sales process has started on the sale of one of the top four global ex-pat healthcare insurers, HBI hears. We name names and potential buyers in what is likely to be a billion dollar plus deal.

Movement at the top of German imaging

Curagita-backed Deutsche Radiologienetz AG (DeRaG), one of the first movers in consolidating the German imaging market, will soon bring in a new investor, HBI can reveal. Meanwhile, ongoing investigations into the founder of Med 360°, the largest player in the market, may raise questions over the future of one of its minority shareholders.

Find Us